Literature DB >> 22052773

Association of reduced total lung capacity with mortality and use of health services.

Claudio Pedone1, Simone Scarlata2, Domenica Chiurco3, Maria Elisabetta Conte3, Francesco Forastiere4, Raffaele Antonelli-Incalzi5.   

Abstract

BACKGROUND: Pulmonary restriction is associated with increased mortality in adults, especially those who are elderly. Previous studies, however, have used the FVC as a surrogate for the total lung capacity (TLC). We evaluated the association between a reduced TLC, mortality, and health-care resources use and compared this association with a reduced FVC.
METHODS: Seven hundred fifty-two patients > 60 years old and undergoing spirometry were recruited. The main analyses were performed in patients without bronchial obstruction (n = 405). Data on mortality and admission to acute care hospitals were derived. Pulmonary restriction was alternatively defined as a TLC or an FVC below the lower limit of normal (LLN). The unadjusted relative risk of mortality associated with pulmonary restriction and adjusted incidence rate ratios (IRRs) were determined. Survival analysis was repeated using time to first hospital admission as the dependent variable.
RESULTS: Overall mortality was significantly higher in the group with reduced TLC compared with the group with lower FVC (10.2 per 100 patients vs 4.27 per 100 patients, respectively), with mortality rate ratios of 6.87 (95% CI, 2.54-18.24) and 2.73 (95% CI, 1.04-7.66), respectively. After adjustment, the hazard ratio (HR) for mortality associated with pulmonary restriction in patients who received diagnoses using the FVC was reduced to 2.05 (95% CI, 0.70-6.02). Reduced TLC remained strongly associated with mortality (HR, 4.52; 95% CI, 1.32-15.51). No association was found between restriction (diagnosed using either parameter) and risk for hospitalization.
CONCLUSIONS: Reduced TLC is strongly associated with mortality in adults who are elderly. Reduction of the FVC is a weaker risk factor for mortality.

Entities:  

Mesh:

Year:  2011        PMID: 22052773     DOI: 10.1378/chest.11-0899

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  Chronic respiratory disease - the acceptable epidemic?

Authors:  Peter Burney
Journal:  Clin Med (Lond)       Date:  2017-02       Impact factor: 2.659

2.  Association between frailty index, lung function, and major clinical determinants in chronic obstructive pulmonary disease.

Authors:  Simone Scarlata; Panaiotis Finamore; Alice Laudisio; Vittorio Cardaci; Mattia Ramaccia; Francesco D'Alessandro; Claudio Pedone; Raffaele Antonelli Incalzi; Matteo Cesari
Journal:  Aging Clin Exp Res       Date:  2021-05-19       Impact factor: 3.636

3.  Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty--a BOLD analysis.

Authors:  Peter Burney; Anamika Jithoo; Bernet Kato; Christer Janson; David Mannino; Ewa Nizankowska-Mogilnicka; Michael Studnicka; Wan Tan; Eric Bateman; Ali Koçabas; William M Vollmer; Thorarrin Gislason; Guy Marks; Parvaiz A Koul; Imed Harrabi; Louisa Gnatiuc; Sonia Buist
Journal:  Thorax       Date:  2013-12-18       Impact factor: 9.139

4.  The Role of Pulmonary Function Test for Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease.

Authors:  Jiangbiao Xiong; Jianbin Li; Yiping Huang; Fan Yang; Rui Wu
Journal:  Dis Markers       Date:  2022-09-29       Impact factor: 3.464

5.  Automated estimation of total lung volume using chest radiographs and deep learning.

Authors:  Ecem Sogancioglu; Keelin Murphy; Ernst Th Scholten; Luuk H Boulogne; Mathias Prokop; Bram van Ginneken
Journal:  Med Phys       Date:  2022-04-18       Impact factor: 4.506

6.  Association of pulse wave velocity with total lung capacity: A cross-sectional analysis of the BOLD London study.

Authors:  André F S Amaral; Jaymini Patel; Louisa Gnatiuc; Meinir Jones; Peter G J Burney
Journal:  Respir Med       Date:  2015-11-02       Impact factor: 3.415

7.  Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?

Authors:  Małgorzata Sobiecka; Katarzyna Lewandowska; Jarosław Kober; Monika Franczuk; Agnieszka Skoczylas; Witold Tomkowski; Jan Kuś; Monika Szturmowicz
Journal:  Lung       Date:  2020-03-23       Impact factor: 2.584

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.